• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非漏槽条件下难溶性药物的剂量依赖性溶解度-渗透性相互作用

Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.

作者信息

Sugita Kazuya, Takata Noriyuki, Yonemochi Etsuo

机构信息

Department of Physical Chemistry, Hoshi University, 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan.

Quality Development Department, Chugai Pharma Manufacturing Co., Ltd., 5-5-1, Ukima, Kita, Tokyo 115-8543, Japan.

出版信息

Pharmaceutics. 2021 Mar 2;13(3):323. doi: 10.3390/pharmaceutics13030323.

DOI:10.3390/pharmaceutics13030323
PMID:33801447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7998705/
Abstract

We investigated the solubility-permeability interplay using a solubilizer additive under non-sink conditions. Sodium lauryl sulfate (SLS) was used as a solubilizer additive. The solubility and permeability of two poorly soluble drugs at various doses, with or without SLS, were evaluated by flux measurements. The total permeated amount of griseofulvin, which has high permeability, increased by the addition of SLS. On the other hand, triamcinolone, which has low permeability, showed an almost constant rate of permeation regardless of the SLS addition. The total permeated amount of griseofulvin increased by about 20-30% when the dose amount exceeded its solubility, whereas its concentration in the donor chamber remained almost constant. However, the total permeated amount of triamcinolone was almost constant regardless of dose amount. These results suggest that the permeability of the unstirred water layer (UWL) may be affected by SLS and solid drugs for high-permeable drugs. The effect of solid drugs could be explained by a reduction in the apparent UWL thickness. For the appropriate evaluation of absorption, it would be essential to consider these effects.

摘要

我们在非漏槽条件下使用增溶剂添加剂研究了溶解度-渗透性相互作用。月桂醇硫酸酯钠(SLS)用作增溶剂添加剂。通过通量测量评估了两种难溶性药物在不同剂量下(有或无SLS)的溶解度和渗透性。加入SLS后,高渗透性的灰黄霉素的总渗透量增加。另一方面,低渗透性的曲安奈德无论是否添加SLS,其渗透速率几乎恒定。当剂量超过其溶解度时,灰黄霉素的总渗透量增加了约20%-30%,而其在供体室中的浓度几乎保持不变。然而,曲安奈德的总渗透量无论剂量如何几乎恒定。这些结果表明,对于高渗透性药物,未搅拌水层(UWL)的渗透性可能受SLS和固体药物的影响。固体药物的作用可以通过表观UWL厚度的减小来解释。为了对吸收进行适当评估,考虑这些影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/cc03b609381f/pharmaceutics-13-00323-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/d66418d35bb7/pharmaceutics-13-00323-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/63ced17dddd5/pharmaceutics-13-00323-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/82ec089572b9/pharmaceutics-13-00323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/89cdd92eb5c6/pharmaceutics-13-00323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/54f740da7f89/pharmaceutics-13-00323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/f4bf04d5b184/pharmaceutics-13-00323-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/85697fdcebbc/pharmaceutics-13-00323-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/4430f5bed643/pharmaceutics-13-00323-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/0d7591416eda/pharmaceutics-13-00323-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/87ee79254df1/pharmaceutics-13-00323-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/d6166877f86a/pharmaceutics-13-00323-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/423af53cd838/pharmaceutics-13-00323-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/cc03b609381f/pharmaceutics-13-00323-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/d66418d35bb7/pharmaceutics-13-00323-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/63ced17dddd5/pharmaceutics-13-00323-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/82ec089572b9/pharmaceutics-13-00323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/89cdd92eb5c6/pharmaceutics-13-00323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/54f740da7f89/pharmaceutics-13-00323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/f4bf04d5b184/pharmaceutics-13-00323-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/85697fdcebbc/pharmaceutics-13-00323-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/4430f5bed643/pharmaceutics-13-00323-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/0d7591416eda/pharmaceutics-13-00323-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/87ee79254df1/pharmaceutics-13-00323-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/d6166877f86a/pharmaceutics-13-00323-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/423af53cd838/pharmaceutics-13-00323-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5123/7998705/cc03b609381f/pharmaceutics-13-00323-g011.jpg

相似文献

1
Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.非漏槽条件下难溶性药物的剂量依赖性溶解度-渗透性相互作用
Pharmaceutics. 2021 Mar 2;13(3):323. doi: 10.3390/pharmaceutics13030323.
2
The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.溶解度-渗透性相互作用:胶束增溶对肠道渗透影响的机制模型及预测应用。
Mol Pharm. 2011 Oct 3;8(5):1848-56. doi: 10.1021/mp200181v. Epub 2011 Aug 11.
3
Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions.非漏槽条件下渗透性对某些纳米颗粒制剂吸收的无效改善作用
Pharmaceutics. 2022 Apr 7;14(4):816. doi: 10.3390/pharmaceutics14040816.
4
An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity.评估未搅动水层和受体池在限制不同亲脂性药物化合物体外肠道通透性方面的相对作用。
J Pharm Pharmacol. 2008 Oct;60(10):1311-9. doi: 10.1211/jpp/60.10.0007.
5
In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.评估难溶性药物口服吸收的体外系统:药物溶出与渗透的同步分析
Pharm Res. 2003 Oct;20(10):1674-80. doi: 10.1023/a:1026107906191.
6
Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling.利用高通量实验和机制吸收模型理解月桂基硫酸钠对几种疏水性药物组合的生物相关溶解度的作用。
J Pharm Pharm Sci. 2019;22(1):221-246. doi: 10.18433/jpps30347.
7
Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.实际建模方法研究无定形药物纳米粒子对难溶性药物口服吸收的影响。
Mol Pharm. 2020 Jan 6;17(1):180-189. doi: 10.1021/acs.molpharmaceut.9b00889. Epub 2019 Dec 6.
8
Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.胃内pH值对口服药物吸收的影响:使用反映胃内溶解过程的溶出/渗透系统进行体外评估。
Eur J Pharm Biopharm. 2016 Apr;101:103-11. doi: 10.1016/j.ejpb.2016.02.002. Epub 2016 Feb 9.
9
Designing a Novel Coamorphous Salt Formulation of Telmisartan with Amlodipine to Enhance Permeability and Oral Absorption.设计一种新型替米沙坦与氨氯地平共无定形盐制剂以提高渗透性和口服吸收。
Mol Pharm. 2023 Aug 7;20(8):4071-4085. doi: 10.1021/acs.molpharmaceut.3c00226. Epub 2023 Jul 27.
10
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.药物发现阶段用于评估候选药物口服吸收的溶出/渗透系统的优势。
Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13.

引用本文的文献

1
Solid lipid nanoparticles for increased oral bioavailability of acalabrutinib in chronic lymphocytic leukaemia.用于提高阿卡拉布替尼在慢性淋巴细胞白血病中口服生物利用度的固体脂质纳米粒
Discov Nano. 2024 Dec 30;19(1):218. doi: 10.1186/s11671-024-04157-8.
2
Novel First-Generation Dissolution Models to Investigate the Release and Uptake of Oral Lymphotropic Drug Products.新型第一代溶出模型研究口服淋巴靶向药物制剂的释放和摄取。
AAPS PharmSciTech. 2024 Aug 14;25(6):187. doi: 10.1208/s12249-024-02866-y.
3
Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions.

本文引用的文献

1
Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.针对含有纳米颗粒的制剂开发有区分力的溶出方法:颗粒漂移和溶液中药物活性的影响。
Mol Pharm. 2020 Nov 2;17(11):4125-4140. doi: 10.1021/acs.molpharmaceut.0c00599. Epub 2020 Oct 21.
2
The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.功能性辅料在固体口服制剂中对克服药物溶出度差和生物利用度低的作用。
Pharmaceutics. 2020 Apr 25;12(5):393. doi: 10.3390/pharmaceutics12050393.
3
The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals.
非漏槽条件下渗透性对某些纳米颗粒制剂吸收的无效改善作用
Pharmaceutics. 2022 Apr 7;14(4):816. doi: 10.3390/pharmaceutics14040816.
4
Amorphous Form of Carvedilol Phosphate-The Case of Divergent Properties.卡维地洛磷酸无定形形式——性质差异的案例。
Molecules. 2021 Sep 1;26(17):5318. doi: 10.3390/molecules26175318.
阐明纳米晶体制剂口服吸收增强的关键因素:纳米晶体的体外-体内相关性。
Eur J Pharm Biopharm. 2020 Jan;146:84-92. doi: 10.1016/j.ejpb.2019.12.002. Epub 2019 Dec 7.
4
Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches.肠道通透性与药物吸收:预测性实验、计算及体内研究方法
Pharmaceutics. 2019 Aug 13;11(8):411. doi: 10.3390/pharmaceutics11080411.
5
The Solubility-Permeability Interplay for Solubility-Enabling Oral Formulations.溶解度-渗透性相互作用在实现溶解性增强的口服制剂中的应用。
Curr Drug Targets. 2019;20(14):1434-1446. doi: 10.2174/1389450120666190717114521.
6
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.成功地口服递送给水难溶性药物既依赖于药物的腔内行为,也依赖于合适的先进药物传递系统。
Eur J Pharm Sci. 2019 Sep 1;137:104967. doi: 10.1016/j.ejps.2019.104967. Epub 2019 Jun 25.
7
Application of a Refined Developability Classification System.精细化可开发性分类系统的应用。
J Pharm Sci. 2019 Mar;108(3):1090-1100. doi: 10.1016/j.xphs.2018.10.044. Epub 2018 Oct 30.
8
Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane.基于人工亲脂膜透过率对伊曲康唑制剂进行排名。
Pharm Res. 2018 Jun 20;35(8):161. doi: 10.1007/s11095-018-2440-3.
9
A Refined Developability Classification System.精细化可开发性分类系统。
J Pharm Sci. 2018 Aug;107(8):2020-2032. doi: 10.1016/j.xphs.2018.03.030. Epub 2018 Apr 14.
10
Active intestinal drug absorption and the solubility-permeability interplay.主动肠道药物吸收与溶解度-渗透性相互作用。
Int J Pharm. 2018 Feb 15;537(1-2):84-93. doi: 10.1016/j.ijpharm.2017.10.058. Epub 2017 Nov 2.